Surveillance, Epidemiology, and End Results (SEER) Program
SOLICITATION ANNOUNCEMENT
Contracting Office Address:
Department of Health and Human Services, National Institutes of Health (NIH), National Cancer Institute (NCI), Office of Acquisitions, 9609 Medical Center Dr. Room 1E138 MSC 9705 Rockville, MD 20892-9705.
Description:
The Surveillance Research Program (SRP) within the Division of Cancer Control and Population Sciences (DCCPS) and the Prevention, Control and Population Sciences Branch (PCPSB) within the Office of Acquisitions (OA), National Cancer Institute, National Institutes of Health, intends to solicit the Surveillance, Epidemiology, and End Results (SEER) Program.
The Product Service Code (PSC) is AN11 - Research and Development. The North American Industry Classification System (NAICS) code is 541712 - Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology). NCI anticipates awarding multiple Indefinite Delivery/Indefinite Quantity (IDIQ) contracts to Offerors capable of performing all aspects of the work described in the Base Statement of Work (SOW) and meeting the mandatory criteria stated therein. The current SEER Base contracts expire on July 31, 2017 and the final Core Infrastructure Task Orders expire on April 30, 2018. It is anticipated that contracts will be awarded on or around May 1, 2018, for a period of performance of 10 years.
The purpose of this acquisition is to obtain the services of population-based central cancer registries to collect and report on population-based cancer incidence, treatment, and survival data. The SEER Program is the NCI's major resource for measuring changes in incidence, morbidity, and mortality associated with cancer. The SEER Program serves three major thrusts of the NCI: cancer control, treatment, and epidemiology. The SEER Program was established in 1973 in response to the National Cancer Act of 1971, which mandated that NCI collect, analyze, and disseminate all data useful in the prevention, diagnosis, and treatment of cancer (Public Law 92-218),
Place of Performance:
The place of performance will be the Contractor's work site.
Set Aside Status:
None.
The RFP will only be available electronically and must be accessed through the
FedBizOpps website (www.fbo.gov) and the National Cancer Institute homepage at
http://rcb.cancer.gov/rcb-internet/index.jsp. All information required for submission of a proposal will be contained in the electronic RFP package. It is the Offeror's responsibility to monitor the above websites for the release of this RFP and amendments, if any. All responsible sources may submit a proposal, which shall be considered by the agency. This notice does not commit the Government to award a contract.
Offerors will be required to submit their proposals online at the NIH electronic Contract Proposal Submission (eCPS) website (https://ecps.nih.gov/NCI/home/) ONLY. Proposals submitted in hard copy (paper) will not be accepted. Proposals submitted by email will not be accepted. Collect calls will not be accepted. Facsimile transmissions will not be accepted.
POTENTIAL OFFERORS WILL BE RESPONSIBLE FOR DOWNLOADING THEIR OWN COPY OF THE RFP AND ANY POSSIBLE AMENDMENTS; FAILURE TO DO SO WILL BE AT YOUR ORGANIZATION'S OWN RISK. ALL INQUIRIES SHALL BE SUBMITTED ELECTRONICALLY TO THE CONTRACTING OFFICER LISTED AS THE POINT OF CONTACT HEREIN.
Points of Contact:
Lee Oliver, Contract Specialist; Phone: 240-276-6527; Email: NCISEER_2018@mail.nih.gov.
Marla Jacobson, Contracting Officer; Phone: 240-276-5267; Email: Marla.Jacobson@nih.gov.
Lee J. Oliver, Contract Specialist, Phone 2402766527, Email NCISEER_2018@mail.nih.gov - Marla Jacobson, Contracting Officer, Phone 240-276-5267, Fax 240-276-5431, Email marla.jacobson@nih.gov
